Directed share issue registered at the Danish Companies Registration Office
The Extra General Meeting in Initiator Pharma A/S (“Initiator Pharma” or “the Company”) decided, on the 11[th] of May 2021, to approve the Board of Directors proposal to execute a directed share issue of approx. SEK 30 million. Registration of the directed share issue at the Danish Companies Registration Office has now taken place and the total number of shares amounts to 35,813,834 and the share capital to DKK 3,760,452.57.Upcoming preferential rights issue As previously communicated, the Company intends to carry out a fully secured preferential rights issue of a total of approximately